Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 1986
Sequential chemo-radiotherapy in locally advanced squamous cell carcinoma of the head and neck
T G Wendt, M Chucholowski, R Hartenstein, et al.
Cancer
|
April 15, 1989
Chemotherapy of invasive thymoma. A retrospective study of 22 cases
N Göldel, L Böning, A Fredrik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 1996
Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
A Gerl, R Lamerz, C Clemm, et al.
Onkologie
|
July 7, 2001
Spontaneous Bleeding in a Patient with Malignant Lymphoma: A Case of Acquired Hemophilia
W. Gesierich, R. Munker, U. Geiersberger, et al.
Klinische Wochenschrift
|
June 1, 1983
[The iodine 131-hippurate clearance for the determination of the nephrotoxic effect of cis-dichlorodiamino-platin (II) (cis-platin, cis-DDP)]
T G Wendt, R Hartenstein, U Büll, et al.
British Journal of Cancer
|
October 1, 1996
Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience
A Gerl, C Clemm, N Schmeller, et al.
British Journal of Cancer
|
October 1, 1995
Prognosis after salvage treatment for unselected male patients with germ cell tumours
A Gerl, C Clemm, N Schmeller, et al.
Onkologie
|
January 19, 2002
Advanced head and neck cancer: long-term results of chemo-radiotherapy, complications and induction of second malignancies
R Munker, L Purmale, U Aydemir, et al.
Oncology
|
January 1, 1987
Benefit and costs of follow-up programs in nonseminomatous germ cell tumors of the stages IIb-IV: the Munich experience
W E Berdel, C Clemm, R Hartenstein, et al.
Deutsche Medizinische Wochenschrift (1946)
|
August 1, 1986
[The Munich follow-up program in advanced non-seminoma testicular tumors. Benefits and costs]
C Clemm, W E Berdel, R Hartenstein, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 1986
Sequential chemo-radiotherapy in locally advanced squamous cell carcinoma of the head and neck
T G Wendt, M Chucholowski, R Hartenstein, et al.
Cancer
|
April 15, 1989
Chemotherapy of invasive thymoma. A retrospective study of 22 cases
N Göldel, L Böning, A Fredrik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 1996
Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
A Gerl, R Lamerz, C Clemm, et al.
Onkologie
|
July 7, 2001
Spontaneous Bleeding in a Patient with Malignant Lymphoma: A Case of Acquired Hemophilia
W. Gesierich, R. Munker, U. Geiersberger, et al.
Klinische Wochenschrift
|
June 1, 1983
[The iodine 131-hippurate clearance for the determination of the nephrotoxic effect of cis-dichlorodiamino-platin (II) (cis-platin, cis-DDP)]
T G Wendt, R Hartenstein, U Büll, et al.
British Journal of Cancer
|
October 1, 1996
Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience
A Gerl, C Clemm, N Schmeller, et al.
British Journal of Cancer
|
October 1, 1995
Prognosis after salvage treatment for unselected male patients with germ cell tumours
A Gerl, C Clemm, N Schmeller, et al.
Onkologie
|
January 19, 2002
Advanced head and neck cancer: long-term results of chemo-radiotherapy, complications and induction of second malignancies
R Munker, L Purmale, U Aydemir, et al.
Oncology
|
January 1, 1987
Benefit and costs of follow-up programs in nonseminomatous germ cell tumors of the stages IIb-IV: the Munich experience
W E Berdel, C Clemm, R Hartenstein, et al.
Deutsche Medizinische Wochenschrift (1946)
|
August 1, 1986
[The Munich follow-up program in advanced non-seminoma testicular tumors. Benefits and costs]
C Clemm, W E Berdel, R Hartenstein, et al.
Page
of 5